A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors. - Uronis, Hope; Jia, Jingquan; Bendell, Johanna; Howard, Leigh; Ready, Neal; Lee, Paula; Starr, Mark; Dellinger, Andrew; Pang, Herbert; Nixon, Andrew; Hurwitz, Herbert (Cancer Chemotherapy & Pharmacology, 2015)